HomeCompareGPX vs PFE

GPX vs PFE: Dividend Comparison 2026

GPX yields 4.80% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $22.2K in total portfolio value· pulled ahead in Year 9
10 years
GPX
GPX
● Live price
4.80%
Share price
$20.85
Annual div
$1.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.4K
Annual income
$651.98
Full GPX calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — GPX vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGPXPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GPX + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GPX pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GPX
Annual income on $10K today (after 15% tax)
$407.67/yr
After 10yr DRIP, annual income (after tax)
$554.18/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,765.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GPX + PFE for your $10,000?

GPX: 50%PFE: 50%
100% PFE50/50100% GPX
Portfolio after 10yr
$38.5K
Annual income
$13,455.35/yr
Blended yield
34.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GPX
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GPX buys
0
PFE buys
0
No recent congressional trades found for GPX or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGPXPFE
Forward yield4.80%6.13%
Annual dividend / share$1.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$27.4K$49.6K
Annual income after 10y$651.98$26,258.71
Total dividends collected$5.7K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: GPX vs PFE ($10,000, DRIP)

YearGPX PortfolioGPX Income/yrPFE PortfolioPFE Income/yrGap
1$11,180$479.62$9,153$693.39+$2.0KGPX
2$12,463$501.11$8,593$849.25+$3.9KGPX
3$13,858$522.11$8,336$1,066.78+$5.5KGPX
4$15,370$542.55$8,437$1,384.80+$6.9KGPX
5$17,009$562.40$9,013$1,875.40+$8.0KGPX
6$18,781$581.63$10,306$2,680.72+$8.5KGPX
7$20,696$600.22$12,820$4,101.38+$7.9KGPX
8$22,763$618.15$17,673$6,826.70+$5.1KGPX
9← crossover$24,992$635.40$27,543$12,591.86$2.6KPFE
10$27,393$651.98$49,560$26,258.71$22.2KPFE

GPX vs PFE: Complete Analysis 2026

GPXStock

GP Strategies Corporation provides performance improvement and learning solutions worldwide. The company operates in two segments, Workforce Excellence and Business Transformation Services. The Workforce Excellence segment offers managed learning services, including strategic learning and development consulting; digital learning content design and development solutions; and a suite of learning operations services, such as managed facilitation and delivery, managed training administration and logistics, help desk support, and event and vendor management. This segment also provides engineering and technical services comprising design, development and delivery of technical work-based learning, plant launch initiatives, engineering design and construction management, fabrication, management, operational excellence consulting, chemical demilitarization, homeland security, emergency management support, and asset management and performance improvement consulting, as well as technical documentation services; EtaPRO performance and condition monitoring system, a suite of real-time digital solutions for facilities and power-generating units; and GPiLEARN+ portal, a web-based off-the-shelf delivery format of technical courses. The Business Transformation Services segment offers custom product sales training and service technical training primarily to automotive manufacturers and service technicians; and organizational development solutions, including strategy, leadership, employee engagement and culture consulting, enterprise technology implementation and adoption, and organization design and business performance consulting. It serves companies in the automotive, financial services and insurance, pharmaceutical, oil and gas, power, chemical, electronics and technology, manufacturing, software, retail, healthcare, education, and food and beverage industries, as well as government agencies. GP Strategies Corporation was founded in 1959 and is headquartered in Columbia, Maryland.

Full GPX Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GPX vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GPX vs SCHDGPX vs JEPIGPX vs OGPX vs KOGPX vs MAINGPX vs JNJGPX vs MRKGPX vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.